Steven Eugene Waggoner, MD
Steven Waggoner, MD, is Division Chief, Gynecologic Oncology, at UH Seidman Cancer Center, and Professor, Obstetrics and Gynecology, at Case Western Reserve University School of Medicine.
Dr. Waggoner is board certified in obstetrics and gynecology as well as gynecologic oncology. His special interests include gynecologic oncology, cervical dysplasia, minimally invasive / endoscopic surgery, oncofertility, hospice and palliative medicine, and complementary and integrative medicine. He joined the UH Cleveland Medical Center staff in 2002.
Dr. Waggoner completed his undergraduate work at University of Puget Sound and earned his medical degree from University of Washington in Seattle. He served a residency in obstetrics and gynecology at University of Chicago and a fellowship in gynecologic oncology at Georgetown University.
A renowned researcher, Dr. Waggoner has received numerous grants for research studies related to cervical, endometrial and ovarian cancers.
He has published more than 100 papers and editorials about his basic and clinical research in peer-reviewed journals and has authored 15 textbook chapters. Dr. Waggoner also has made abstract presentations at national medical meetings and been an invited speaker at numerous national, regional and international meetings.
Dr. Waggoner is a member of the NRG Oncology Ancillary Protocol Committee and Membership Committee. He serves as a Principal Investigator for NRG Oncology and GOG Foundation activities at University Hospitals Cleveland Medical Center.
- Cervical Dysplasia
- Gynecological Oncology
- Obstetrics and Gynecology
- Ovarian Cancer
- Quality of Life
- President’s Award, 21st Annual Meeting, Society of Gynecologic Oncologists, 1990
- President’s Award, 22nd Annual Meeting, Society of Gynecologic Oncologists, 1991
- American Cancer Society Clinical Oncology Career Development Award, 1992-1995
- Castle Connolly “America’s Top Doctor” Citation, 2003-14
- Castle Connolly “America’s Top Doctors for Cancer” Citation Oncologists, 2005-14
UH Minoff Health Center at Chagrin Highlands
3909 Orange Pl
Beachwood OH, 44122
Patient Satisfaction Reviews
5 out of 5
Patient Comments (3)
Reviewed On 6/16/2018
Dr. Waggoner is the best GYN oncologist anywhere in my opinion. He is an excellent surgeon, very compassionate and thorough as well as very professional. I can't say enough about him -- have been his patient for more than a decade and would find anyone else lacking -- he is THE BEST.
Reviewed On 5/29/2018
Dr. Waggoner is a great, gentle and very kind man. At my last visit I had some personal things to share. He and the nurse were very responsive and patient as I needed some time to explain something. After the discussion he made sure that I was ready for the exam that he had to perform. He is among the finest doctors I have ever seen and had to have as a health care provider. Too bad he's a specialist and not available to be my primary care physician!
Reviewed On 5/27/2018
very compassionate Dr listened what my concerns are explains his care plan. asks questions I may have not thought of asking. have total trust and respect for his knowledge in the care I need.
- Gynecologic Oncology - American Board of Obstetrics and Gynecology
- Obstetrics and Gynecology - American Board of Obstetrics and Gynecology
Fellowship | Gynecologic Oncology
Gynecologic Oncology - Georgetown University Hospital (1988 - 1991)
Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - University Of Chicago Medical Center (1985 - 1988)
Internship | Obstetrics and Gynecology
Obstetrics and Gynecology - University Of Chicago Medical Center (1984 - 1985)
University Of Washington (1984)
University Of Puget Sound (1980)
Gynecologic malignancies, Cervical dysplasia, Obesity and endometrial cancer
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Steven Eugene Waggoner did not disclose any Outside Relationships with Industry.